1[1]Gjertson DW,Cecka JM,Tarasaki PI.The relative effects of FK506 and cyclosporine on short and long-term kidney graft survival[J].Transplantation,1995,60(8):1384-1388.
2[2]Kahan BD,Welsh M,Schoenberg L,et al.Variable oral absorption of cyclosporine[J].Transplantation,1996,62(3):599-606.
3[3]Keown P,Niese D.Cyclosporine microemulsion increases during exposure and educes acute rejection without incremental toxicity in de novo renal transplantation[J].Kidney International,1998,54(5):938-944.
5[5]Mahalati K,Belitsky P,Sketris I,et al.Neoral monitoring by simplified sparse sampling area under the concentration-time curve[J].Transplantation,1999,68(1):55-62.
6[6]Barama A,Perner F,Beauregard-Zollinger L,et al.Absorption Profiling of cyclosporine therapy for de nove kidney transplantation:a prospective,randomized study comparing sparse sampling to trough monitoring[J].Transplantation,2000,69(8):S162.
7[7]Halloran PF,Helms LM,Kung L,et al.The temporal profile of calcineurin inhibition by cyclosporine in vivo[J].Transplantation,1999,68(6):1356-1361.
8[8]Levy GA,Lake JR,Beauregard-Zollinger L.Improved clinical outcomes for liver transplant recipients using cyclosporine blood lever monitoring based on two-hour post-dose levers[J].Transplantation,2000,69(8):S387.
9[9]Pescovitz MD,Barbeito R.Effect of C2 cyclosporine levels and time to initiation of cyclosporine therapy on outcomes in patients receiving Neoral and Simulect[J].J Am Soc Nephrol,2000,11(Program and Abstract Issue):703A.
10[10]Pfeffer P,Stefoni S,Carreno C,et al,for the MO2ART Study Group.Monitoring of 2-hour Neoral absorption in renal transplantation shows low incidence of acute rejection in the early post-graft period:interim results of the MO2ART study[M].American Society of Transplantation Congress,April 16-May 1,2002,Washington DC.[Abstract 1037].
